back to cluster viewer
cluster path 101111110111010
74 words, 7,470 tokens
freq alpha suffix
Words in frequency order
1 | full | 7,140
|
2 | microsoft | 62
|
3 | bloodless | 38
|
4 | mid-course | 16
|
5 | wet-dry | 15
|
6 | trieger | 14
|
7 | base-in | 12
|
8 | semicontinuous | 11
|
9 | back-to-back | 10
|
10 | mid-frequency | 10
|
11 | pre-implementation | 10
|
12 | piga1 | 9
|
13 | time-to-full | 9
|
14 | multiauthored | 6
|
15 | scramble | 6
|
16 | bicolumnar | 5
|
17 | small-quantity | 5
|
18 | 1.0-mg | 4
|
19 | 1.5-kcal/ml | 4
|
20 | base-out | 3
|
21 | ga-mediated | 3
|
22 | mid-normal | 3
|
23 | multivolume | 3
|
24 | nonvolunteer | 3
|
25 | parallax-free | 3
|
26 | postvasectomy | 3
|
27 | 24-s | 2
|
28 | 3,366 | 2
|
29 | 3-segmented | 2
|
30 | 8129 | 2
|
31 | immunoenhanced | 2
|
32 | isomaltulose-based | 2
|
33 | native- | 2
|
34 | non-dextran | 2
|
35 | non-omalizumab | 2
|
36 | omnisports | 2
|
37 | otwal | 2
|
38 | pager-based | 2
|
39 | paranuclear | 2
|
40 | starry | 2
|
41 | tuanalyze | 2
|
42 | 'starry | 1
|
43 | -17.3±3.5 | 1
|
44 | abagovomab-induced | 1
|
45 | arrb2 | 1
|
46 | briefest | 1
|
47 | cd-functionalized | 1
|
48 | challenge.this | 1
|
49 | ea2-causing | 1
|
50 | fe-containing | 1
|
51 | gigascience | 1
|
52 | injection-time | 1
|
53 | kjp | 1
|
54 | levosimendan-induced | 1
|
55 | lower-case | 1
|
56 | microsoft® | 1
|
57 | millimeter-scaled | 1
|
58 | miscarriage.most | 1
|
59 | mobile-telephone | 1
|
60 | noaa-funded | 1
|
61 | pcr-reversed | 1
|
62 | protein-energy-enriched | 1
|
63 | racially/ethnic | 1
|
64 | registry-linked | 1
|
65 | shadier | 1
|
66 | smartxide | 1
|
67 | spotlight-virtual | 1
|
68 | t2.the | 1
|
69 | thought-provocative | 1
|
70 | timed-out | 1
|
71 | top-box | 1
|
72 | treiger | 1
|
73 | us-enhanced | 1
|
74 | «perceive | 1
|
Words in alphabetical order
1 | 'starry | 1
|
2 | -17.3±3.5 | 1
|
3 | 1.0-mg | 4
|
4 | 1.5-kcal/ml | 4
|
5 | 24-s | 2
|
6 | 3,366 | 2
|
7 | 3-segmented | 2
|
8 | 8129 | 2
|
9 | abagovomab-induced | 1
|
10 | arrb2 | 1
|
11 | back-to-back | 10
|
12 | base-in | 12
|
13 | base-out | 3
|
14 | bicolumnar | 5
|
15 | bloodless | 38
|
16 | briefest | 1
|
17 | cd-functionalized | 1
|
18 | challenge.this | 1
|
19 | ea2-causing | 1
|
20 | fe-containing | 1
|
21 | full | 7,140
|
22 | ga-mediated | 3
|
23 | gigascience | 1
|
24 | immunoenhanced | 2
|
25 | injection-time | 1
|
26 | isomaltulose-based | 2
|
27 | kjp | 1
|
28 | levosimendan-induced | 1
|
29 | lower-case | 1
|
30 | microsoft | 62
|
31 | microsoft® | 1
|
32 | mid-course | 16
|
33 | mid-frequency | 10
|
34 | mid-normal | 3
|
35 | millimeter-scaled | 1
|
36 | miscarriage.most | 1
|
37 | mobile-telephone | 1
|
38 | multiauthored | 6
|
39 | multivolume | 3
|
40 | native- | 2
|
41 | noaa-funded | 1
|
42 | non-dextran | 2
|
43 | non-omalizumab | 2
|
44 | nonvolunteer | 3
|
45 | omnisports | 2
|
46 | otwal | 2
|
47 | pager-based | 2
|
48 | parallax-free | 3
|
49 | paranuclear | 2
|
50 | pcr-reversed | 1
|
51 | piga1 | 9
|
52 | postvasectomy | 3
|
53 | pre-implementation | 10
|
54 | protein-energy-enriched | 1
|
55 | racially/ethnic | 1
|
56 | registry-linked | 1
|
57 | scramble | 6
|
58 | semicontinuous | 11
|
59 | shadier | 1
|
60 | small-quantity | 5
|
61 | smartxide | 1
|
62 | spotlight-virtual | 1
|
63 | starry | 2
|
64 | t2.the | 1
|
65 | thought-provocative | 1
|
66 | time-to-full | 9
|
67 | timed-out | 1
|
68 | top-box | 1
|
69 | treiger | 1
|
70 | trieger | 14
|
71 | tuanalyze | 2
|
72 | us-enhanced | 1
|
73 | wet-dry | 15
|
74 | «perceive | 1
|
Words in suffix order
1 | native- | 2
|
2 | piga1 | 9
|
3 | arrb2 | 1
|
4 | -17.3±3.5 | 1
|
5 | 3,366 | 2
|
6 | 8129 | 2
|
7 | non-omalizumab | 2
|
8 | racially/ethnic | 1
|
9 | us-enhanced | 1
|
10 | immunoenhanced | 2
|
11 | abagovomab-induced | 1
|
12 | levosimendan-induced | 1
|
13 | noaa-funded | 1
|
14 | protein-energy-enriched | 1
|
15 | registry-linked | 1
|
16 | millimeter-scaled | 1
|
17 | multiauthored | 6
|
18 | isomaltulose-based | 2
|
19 | pager-based | 2
|
20 | pcr-reversed | 1
|
21 | ga-mediated | 3
|
22 | 3-segmented | 2
|
23 | cd-functionalized | 1
|
24 | gigascience | 1
|
25 | smartxide | 1
|
26 | parallax-free | 3
|
27 | t2.the | 1
|
28 | scramble | 6
|
29 | injection-time | 1
|
30 | multivolume | 3
|
31 | mobile-telephone | 1
|
32 | lower-case | 1
|
33 | mid-course | 16
|
34 | «perceive | 1
|
35 | thought-provocative | 1
|
36 | tuanalyze | 2
|
37 | 1.0-mg | 4
|
38 | fe-containing | 1
|
39 | ea2-causing | 1
|
40 | back-to-back | 10
|
41 | mid-normal | 3
|
42 | spotlight-virtual | 1
|
43 | otwal | 2
|
44 | full | 7,140
|
45 | time-to-full | 9
|
46 | 1.5-kcal/ml | 4
|
47 | non-dextran | 2
|
48 | base-in | 12
|
49 | pre-implementation | 10
|
50 | kjp | 1
|
51 | paranuclear | 2
|
52 | bicolumnar | 5
|
53 | nonvolunteer | 3
|
54 | trieger | 14
|
55 | treiger | 1
|
56 | shadier | 1
|
57 | 24-s | 2
|
58 | challenge.this | 1
|
59 | bloodless | 38
|
60 | omnisports | 2
|
61 | semicontinuous | 11
|
62 | microsoft | 62
|
63 | briefest | 1
|
64 | miscarriage.most | 1
|
65 | timed-out | 1
|
66 | base-out | 3
|
67 | top-box | 1
|
68 | mid-frequency | 10
|
69 | postvasectomy | 3
|
70 | wet-dry | 15
|
71 | starry | 2
|
72 | 'starry | 1
|
73 | small-quantity | 5
|
74 | microsoft® | 1
|